Provided by Tiger Trade Technology Pte. Ltd.

Veracyte

42.91
-0.9550-2.18%
Volume:182.28K
Turnover:7.86M
Market Cap:3.45B
PE:30.77
High:43.78
Open:43.18
Low:42.50
Close:43.86
52wk High:60.91
52wk Low:29.46
Shares:80.39M
Float Shares:78.97M
Volume Ratio:0.33
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.39
EPS(LYR):0.8200
ROE:8.77%
ROA:4.09%
PB:2.48
PE(LYR):52.32

Loading ...

Veracyte Outlook 2026 - Continues to Expect Adjusted Ebitda Margin to be Greater than 26%

THOMSON REUTERS
·
Jul 31

Veracyte Q2 EPS USD 0.31

THOMSON REUTERS
·
Jul 31

Veracyte Outlook FY Revenue Growth 14-15%

THOMSON REUTERS
·
Jul 31

Veracyte Q2 Gross Margin 72%

THOMSON REUTERS
·
Jul 31

Veracyte: Outlook 2026 Raises Testing Revenue Guidance to $576 Million to $582 Million

THOMSON REUTERS
·
Jul 31

Veracyte Announces Second Quarter 2026 Financial Results

GlobeNewswire
·
Jul 31

Veracyte to Present at Canaccord Genuity Growth Conference Fireside Chat

Reuters
·
Jul 29

Veracyte to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Jul 29

Earning Preview: Veracyte revenue is expected to increase by 19.80% this quarter, and institutional views are bullish

Earnings Agent
·
Jul 24

Can Veracyte (VCYT) Stay Reasonable After A 145% Rally?

Simply Wall St.
·
Jul 17

Piper Sandler Initiates Veracyte at Overweight With $66 Price Target

MT Newswires Live
·
Jul 15

Veracyte Initiated at Overweight by Piper Sandler

Dow Jones
·
Jul 15

Veracyte Inc : Piper Sandler Initiates Coverage with Overweight Rating; Price Target $66

THOMSON REUTERS
·
Jul 15

Veracyte is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Jul 14

Veracyte price target raised to $60 from $42 at Canaccord

TIPRANKS
·
Jul 14

Press Release: Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026

Dow Jones
·
Jul 10

Veracyte to Report Q2 Results, Host Conference Call

Reuters
·
Jul 10

Veracyte is Maintained at Underweight by Morgan Stanley

Dow Jones
·
Jul 10

Veracyte Inc : Morgan Stanley Raises Target Price to $47.00 from $37.00

THOMSON REUTERS
·
Jul 09

Veracyte price target raised to $47 from $37 at Morgan Stanley

TIPRANKS
·
Jul 09